During the 10 years since publication of the first edition of
this comprehensive volume, progress in neuroscience has had direct
and immediate clinical implications in both the pharmacological and
psychological arenas in the treatment of one of psychiatry's
greatest challenges: obsessive-compulsive disorder (OCD).
This second edition reflects this progress. Chapters include the
latest data on the use of all current OCD treatments in special
populations, such as the strictly religious, the elderly, children,
adolescents, and those who are pregnant, and all are illustrated
with new and updated detailed case histories that highlight
specific treatments and diagnostic issues. This edition includes -
Three new pharmacotherapy chapters that discuss the use of
sertraline, paroxetine, and citalopram and updates of the original
edition's chapters on clomipramine, fluoxetine, and fluvoxamine- An
expanded chapter on children and adolescents that emphasizes the
benefits of early detection, and describes the latest findings in
immunological research with particular regard to pediatric
autoimmune neurologic disorders associated with streptococcal
infection (PANDAS) - An expanded behavioral therapy chapter that
encompasses not only detailed treatment plans for both individuals
and groups (including multifamily groups) but also up-to-date
empirical data to support their use- The latest data on compounds
for treating OCD (twice the number of compounds are now available
than when the first edition was published), including details of
the dramatic increase in our knowledge of pharmacokinetics,
receptor profiles, interactions, and comparative efficacy during
the past decade- The clinical implications of today's broadened
definition of OCD, which includes disorders such as body dysmorphic
disorder, trichotillomania, pathological gambling, and Tourette's
syndrome, and the complicated diagnostic and management issues --
with a call for innovative treatment approaches -- raised by the
intimate relationship between OCD and schizophrenia (15% of
patients with schizophrenia also have OCD)- A multidisciplinary
approach to treatment-resistant OCD, which occurs in approximately
30% of all cases, suggesting ways to combine our current knowledge
and focus it on the treatment of a specific individual
With their extensive clinical and research experience in
treating OCD, the distinguished contributors to this volume provide
clinicians with the latest, most reliable data so that they may
better match treatment approaches with each patient's unique needs.
Of enduring practical value, this updated "how to" manual will be
welcomed by all clinicians treating patients with OCD, as well as
students and other interested clinicians, as an effective tool in
the ongoing challenge to understand and treat this frustrating
disorder.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!